Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL628733 | 0.95 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL8862271 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL16232791 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL17165007 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL4376195 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL15418383 | 0.91 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL4371967 | 0.91 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL11505039 | 0.90 | ALDH1A1 (0.47) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL166842 | 0.88 | ALDH1A1 (0.58) | ALDH1A1CYP3A4TSHRTDP1CA2 | |
| SCHEMBL14839899 | 0.88 | ALDH1A1 (0.52) | ALDH1A1CYP3A4TSHRTDP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4654432-A | Preparation of 2-(hydroxymethyl)-acrylonitrile and 2-(hydroxymethyl)-acrylates | BASF AKTIENGESELLSCHAFT (DE) | 1987-03-31 | — | — | US | claimed |
| US-20090035696-A1 | PHOTORESIST COMPOSITION | KYOWA HAKKO CHEMICAL CO., LTD. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20080287684-A1 | Method for Producing Ionic Liquids | BASF SE (DE) | 2008-11-20 | — | — | US | disclosed |
| EP-1957472-A1 | METHOD FOR PRODUCING IONIC LIQUIDS | BASF SE (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1832571-A1 | Process for producing hydroxyl group-containing vinyl compound | FUJIFILM Corporation (JP) | 2007-09-12 | — | — | EP | disclosed |
| WO-2007057403-A1 | METHOD FOR PRODUCING IONIC LIQUIDS | BASF SE (DE) | 2007-05-24 | — | — | WO | disclosed |
| US-6160169-A | Preparation of amine salts of 4-nitrotoluene-2-sulfonic acid | BASF AKTIENGESELLSCHAFT (DE) | 2000-12-12 | — | — | US | disclosed |
| US-5892105-A | Preparation of amine salts of 4-nitrotoluene-2-sulfonic acid | BASF AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | disclosed |
| EP-0259849-B1 | PROCESS FOR THE PREPARATION OF C.I. VAT BLUE 16 | BASF Aktiengesellschaft (DE) | 1991-10-16 | — | — | EP | disclosed |
| US-4824608-A | ALKYLATING 16,17-DIHYDROXYVIOLANTHRENE-5,10-DIONE IN TERTIARY ALIPHATIC OR CYCLOALIPHATIC AMINE AS SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 1989-04-25 | — | — | US | disclosed |
| EP-0185234-B1 | 2-(1-HYDROXYCARBALKOXYMETHYL) ACRYLONITRILE AND ACRYLATE ESTERS, AND PROCESS FOR THEIR PREPARATION | BASF Aktiengesellschaft (DE) | 1988-06-01 | — | — | EP | disclosed |
| EP-0259849-A2 | Process for the preparation of C.I. vat blue 16 | BASF Aktiengesellschaft (DE) | 1988-03-16 | — | — | EP | disclosed |
| US-4654432-A | Preparation of 2-(hydroxymethyl)-acrylonitrile and 2-(hydroxymethyl)-acrylates | BASF AKTIENGESELLSCHAFT (DE) | 1987-03-31 | — | — | US | disclosed |
| US-4652669-A | MONOMERS | BASF AKTIENGESELLSCHAFT (DE) | 1987-03-24 | — | — | US | disclosed |
| EP-0185234-A1 | 2-(1-Hydroxycarbalkoxymethyl) acrylonitrile and acrylate esters, and process for their preparation | BASF Aktiengesellschaft (DE) | 1986-06-25 | — | — | EP | disclosed |
| EP-0184731-A1 | Process for the preparation of 2-(1-hydroxymethyl) acrylonitrile and acrylates | BASF Aktiengesellschaft (DE) | 1986-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287684-A1 | Method for Producing Ionic Liquids | HACL2, HAO2, SLC6A12 | ALDH1A1 909/4885CYP3A4 3044/4885TSHR 1407/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.